Tuesday, February 5, 2019

rheumatic diseases

There are no recent studies that have quantified mortality in JRA, however the mortality range is less than 1% and is often associated with the evolution of the disease to manifestations of other rheumatic diseases, such as systemic lupus erythematosus or scleroderma.

The most typical type of morbidity in patients with JRA is related to the side effects of the medications used, particularly non-steroidal anti-inflammatory analgesics; abdominal pain in relation to gastritis or ulcerative disease, hepatotoxicity and more rarely renal toxicity Flekosteel.

No comments:

Post a Comment